X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
neurology (4) 4
humans (3) 3
index medicus (3) 3
medicine (3) 3
multiple sclerosis (3) 3
science (3) 3
adult (2) 2
female (2) 2
hospitals (2) 2
interferon (2) 2
interferon beta-1a (2) 2
interferon-beta - therapeutic use (2) 2
male (2) 2
mathematical analysis (2) 2
medical research (2) 2
medicine, experimental (2) 2
multidisciplinary sciences (2) 2
patients (2) 2
studies (2) 2
time factors (2) 2
25-hydroxyvitamin d (1) 1
adherence (1) 1
age factors (1) 1
aged (1) 1
aged, 80 and over (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
australia (1) 1
bias (1) 1
biological response modifiers (1) 1
birth (1) 1
brain research (1) 1
clinical epidemiology (1) 1
clinical medicine (1) 1
clinical outcomes (1) 1
clinics (1) 1
cohort studies (1) 1
collaboration (1) 1
comparative analysis (1) 1
data bases (1) 1
databases, factual (1) 1
demographic variables (1) 1
demographics (1) 1
demography (1) 1
demyelinating disorders (1) 1
diagnostic-criteria (1) 1
disease-modifying drugs (1) 1
dosage (1) 1
dose-response relationship, drug (1) 1
drug administration schedule (1) 1
drug dosages (1) 1
drug therapy (1) 1
drugs (1) 1
environmental risk-factors (1) 1
epidemiology (1) 1
ethics (1) 1
europe (1) 1
gender (1) 1
gender differences (1) 1
geographical variations (1) 1
geography (1) 1
glatiramer acetate (1) 1
guidelines (1) 1
health care policy (1) 1
human geography (1) 1
immunotherapy (1) 1
immunotherapy - methods (1) 1
immunotherapy - utilization (1) 1
increasing incidence (1) 1
injections, subcutaneous (1) 1
interferon beta (1) 1
interferon-beta (1) 1
interferon-beta - administration & dosage (1) 1
interferon-beta - pharmacology (1) 1
intolerance (1) 1
kaplan-meier estimate (1) 1
latitude (1) 1
lesions (1) 1
likelihood functions (1) 1
magnetic resonance imaging (1) 1
mathematics (1) 1
medical services (1) 1
medical treatment (1) 1
medication adherence (1) 1
medication adherence - statistics & numerical data (1) 1
middle aged (1) 1
multiple sclerosis - diagnosis (1) 1
multiple sclerosis - drug therapy (1) 1
multiple sclerosis - epidemiology (1) 1
multiple sclerosis, chronic progressive - diagnosis (1) 1
multiple sclerosis, chronic progressive - epidemiology (1) 1
multiple sclerosis, relapsing-remitting - diagnosis (1) 1
multiple sclerosis, relapsing-remitting - drug therapy (1) 1
multiple sclerosis, relapsing-remitting - epidemiology (1) 1
multiple sclerosis, relapsing-remitting - immunology (1) 1
natalizumab (1) 1
neurosciences (1) 1
new zealand (1) 1
non-clinical medicine (1) 1
patient compliance (1) 1
patient outcomes (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS One, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, pp. e48078 - e48078
Journal Article
PLoS One, ISSN 1932-6203, 2013, Volume 8, Issue 5, pp. e63480 - e63480
Journal Article
Journal Article
Journal of Clinical Neuroscience, ISSN 0967-5868, 11/2014, Volume 21, Issue 11, p. 2035
Journal Article
Journal of Clinical Neuroscience, ISSN 0967-5868, 11/2014, Volume 21, Issue 11, pp. 2035 - 2036
This study aimed to compare the effectiveness of fingolimod with interferon beta or glatiramer acetate (IFN/GA) as second line agents in reducing relapse... 
Journal Article
Journal of Clinical Neuroscience, ISSN 0967-5868, 11/2014, Volume 21, Issue 11, pp. 2035 - 2036
Journal Article
Journal of Clinical Neuroscience, ISSN 0967-5868, 2014, Volume 21, Issue 11, pp. 2035 - 2036
This study aimed to compare the effectiveness of fingolimod with interferon beta or glatiramer acetate (IFN/GA) as second line agents in reducing relapse... 
Neurology
Journal Article
ISSN 1474-4422, 2017
Background Alemtuzumab, an anti-CD52 antibody, is proven to be more efficacious than interferon beta-1a in the treatment of relapsing-remitting multiple... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.